Reverse left ventricular remodeling is more likely in non ischemic cardiomyopathy patients upgraded to biventricular stimulation after chronic right ventricular pacing by Morales, Maria-Aurora et al.
RESEARCH Open Access
Reverse left ventricular remodeling is more likely
in non ischemic cardiomyopathy patients
upgraded to biventricular stimulation after






2 and Marcello Piacenti
1
Abstract
Background: Chronic right ventricular (RV) apical pacing may lead to left ventricular (LV) dyssynchrony and LV
dysfunction. In heart failure due to RV pacing, upgrading to biventricular stimulation (CRT) can improve NYHA Class
and LV function. A proportion of patients do not respond to upgrading. Aim was to assess whether etiology of LV
dysfunction accounts for responses to CRT in RV-paced patients.
Methods: Sixty-two patients treated by CRT, under RV pacing from 50.2 ± 5.4 months, were studied. Cause of LV
dysfunction was non-ischemic (NIC) in 28 and ischemic cardiomyopathy (IC) in 34 patients. Clinical and
conventional echocardiographic parameters were available within 1 month before RV pacing, within 1 month
before CRT and at 12 ± 2 months of follow-up (FU).
Results: Decreased LVEF (from 37.0 ± 8.8 to 25.6 ± 6.1%, p <0.001), increased LV end-systolic dimensions (LVESD)
(from 48.1 ± 8.6 to 55.2 ± 7.9 mm, p <0.001) and worsened NYHA Class (from 1.9 ± 1.1 to 3.2 ± .6, p < 0.005) were
found before CRT, compared to pre RV-pacing. After CRT, 44/62 patients showed a ≥ 1 NYHA Class improvement;
>10% decrease in LVESD was observed in 24 patients: 5 with IC, 19 with NIC (p < .0.001). The association between
cause of LV dysfunction with >10% decrease in LVESD remained highly significant (p < 0.001) adjusting for pre-CRT
QRS duration, NYHA Class, LVEF, LVESD, treatment or RV pacing duration.
Conclusions: CRT improves functional class even after long-lasting pacing. Reverse remodeling is evident in a
small population, more likely with NIC.
Keywords: congestive heart failure, biventricular stimulation, non-ischemic cardiomyopathy, ischemic
cardiomyopathy
Background
Cardiac resynchronization therapy (CRT) is an estab-
lished treatment for patients with drug refractory heart
failure (HF) and left bundle branch block (LBBB) since
it improves symptoms, quality of life and functional
capacity [1,2], leading to reduction of hospitalizations
for heart failure and death [3,4].
Like native left bundle branch block (LBBB), right api-
cal ventricular (RV) pacing may result in intra- and
interventricular dyssynchrony and development of LV
remodeling due to an abnormal sequence of left ventri-
cular activation [5-11].
Upgrading to CRT in RV paced patients has been
shown to determine symptomatic and functional
improvement comparable to that observed in non-paced
LBBB patients [12-15]. Upgrading may also induce sig-
nificant reverse remodeling in pacemaker-dependent
patients [15]. However, until now, the clinical settings
and conditions for upgrading conventional RV pacing to
resynchronization have not been defined [16]: a percen-
tage of patients still do not respond to upgrading, and
conflicting results are reported on the role of underlying * Correspondence: morales@ifc.cnr.it
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patients [14,15].
In patients with ischemic cardiomyopathy CRT leads
to a less significant improvement in left ventricular ejec-
tion fraction and reduction in left ventricular end-systo-
lic volume than in patients with non-ischemic disease at
mid-and long-term follow-up [17,18].
Therefore, the aim of this study was to assess whether
the underlying cause of LV dysfunction may influence
CRT-induced LV reverse remodeling in patients already
under conventional RV apical pacing.
Methods
Patient population. We retrospectively studied 62 conse-
cutive patients admitted to our Institute for upgrading
to biventricular pacing from April 2007 to December
2009 in sinus rhythm or atrial paced rhythm. Criteria
for implantation were represented by NYHA Class =>III
and LVEF < 35% under optimal medical therapy.
Among patients with history of ischemic heart disease,
only those with no active ischemia, assessed by either
myocardial scintigraphy or dypiridamole echocardiogra-
phy within 2 weeks before LV lead implant, and who
had no indications to coronary revascularization, were
enrolled in the study.
Fifty-one were males, mean age 73 ± 1.0 years; all
patients were under continuous RV apical pacing for
51.2 ± 38.9 months (range 3 to 170 months), with mean
QRS duration 180 ± 20 msec. At time of hospital admis-
sion patients were in NYHA Class III (n. 38) or IV
(n.14) and were under optimal therapy with diuretics,
ACE inhibitors or ATII blockers and beta blockers at
maximal tolerated dosages before upgrading. Forty-eight
patients were also under antialdosterone treatment.
Before upgrading, patients were defined as having
ischemic cardiomyopathy (IC) if they had a history of
myocardial infarction, and/or a history of coronary
artery by-pass graft and/or angioplasty and/or a coron-
ary angiogram indicating major disease. Patients were
diagnosed as having non ischemic cardiomyopathy when
no coronary artery disease could be detected by coron-
ary angiography, significant valvular disease by conven-
tional echocardiography and there was no
documentation of myocarditis in their clinical history.
On this basis the underlying cause of LV dysfunction
was non-ischemic cardiomyopathy (NIC) in 28 and IC
in 34 patients.
Seventeen patients had an implantable cardioverter
defibrillator (ICD) that was upgraded to a CRT device,
35 patients had a pacemaker upgraded to CRT-Pace
maker and 10 to CRT-Defibrillator.
LV leads were implanted by a transvenous approach
through the coronary sinus and positioned in a postero-
lateral, lateral or anterolateral cardiac vein. LV lead
position was assessed by an experienced radiologist and
cardiologist in all patients before hospital discharge. In
all patients the devices were programmed in rate
responsive dual-chamber mode, and atrio-ventricular
d e l a yw a so p t i m i z e db e f o r ed i s c h a r g eb yap r e v i o u s l y
published method which takes into account the Doppler
derived dP/dt by the mitral regurgitation jet [19].
Echocardiographic examination
A standard transthoracic echocardiogram was performed
by commercially available instruments (Acuson Sequoia,
Acuson Corporation, Mountain View, CA, USA; Vivid
system 7, GE/Vingmed, Milwakee, WI, USA). LV end-
diastolic dimensions (LVEDD) and LV end-systolic
d i m e n s i o n s( L V E S D )w e r eo b t a i n e df r o mM - m o d e
recordings derived from 2D echocardiograms of the LV
transverse axis. These were obtained using the paraster-
nal long axis approach with the M-mode cursor posi-
tioned at the tips of the mitral valve leaflets, using the
leading-edge methods, according to recommendations of
the American Society of Echocardiography. LV end-dia-
stolic and systolic volumes and derived ejection fraction
were assessed by the biplane summation method from
the apical 4-chamber view [20].
Clinical and functional parameters by 2D echocardio-
graphy were available in all patients in three conditions:
1) within 1 month before first implant of RV pacing, 2)
within 1 month before implantation of the LV lead and
3) at a mean of 12 ± 4 months follow-up (FU) after
CRT. Before CRT, wall motion score index was also cal-
cutated in all patients and mitral regurgitation severity
determined semiquantitatively from color Doppler
images obtained from the conventional parasternal long
axis and apical views using the regurgitant jet area to
LA area ratio [21]. The following score was used: 1:
mild regurgitation, 2: moderate and 3: severe insuffi-
ciency. All echocardiograms were recorded and stored
for off-line analysis by two reviewers blind to patient
name and date of examination.
The investigation conforms with the principles out-
lined in the Declaration of Helsinki (Br 6 Med J 1964,
ii:177).
Statistical analysis
Results are presented as means ± SD. Changes in con-
tinuous variables before and after procedures were com-
pared using paired Student’s t-test. Analysis of variance
was performed for comparing data between patients
with NIC or IC and between patients with and without
reverse remodeling. The chi-square test was used to
compare categorical variables. A multiple logistic regres-
sion was used to assess the association between etiology
(NIC or IC) and LV remodeling, categorized as >10% or
< = 10% decrease in LVESD, adjusted for clinical and
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statistically significant.
Results
Before conventional PM implantation 22 patients were
in NYHA Class I, 35 in NYHA Class II and 5 in NYHA
C l a s sI I I .M e a nL V E Fw a s3 7 . 0±8 . 9 %( r a n g e1 8t o
6 0 % ) .N o r m a lL Vf u n c t i o na t2 DE c h o( L V E F> o r=
50%) was reported in 12 patients. All pre conventional
PM implantation parameters were extracted by review-
ing hospital charts of the studied population.
At time of CRT implantation, average right ventricular
stimulation was > 90% (range 85 to 99%). When pre-
upgrading data were compared to pre-conventional pace
maker (PM) implantation, a significant worsening in
NYHA Class (from 1.9 ± 1.1 to 3.2 ± .6, p < 0.005)
along with a decrease in LVEF (from 37.0 ± 8.9 to 25.6
± 6.1%, p <0.001), increase in LVEDD (from 60.9 ± 6.6
to 65.2 ± 7.7 mm, p <0.001) and LVESD (from 48.1 ±
8.6 to 55.2 ± 7.9 mm, p <0.001) were found in the stu-
died population. In the subgroup of patients with a nor-
mal LV function before conventional PM implantation
L V E Fc h a n g e df r o m5 2 . 8+3t o2 9 . 6+6( p<0 . 0 0 0 1 ) .
In Figure 1 changes in LVEF for each studied patient
from pre conventional PM implantation to pre CRT are
reported. No relation could be reported between
decreased LVEF and the duration of RV apical pacing at
time of CRT. Twenty-six patients had a history of myo-
cardial infarction before conventional PM implantation.
However, none of the patients had documentation of
myocardial infarction or acute coronary syndrome
requiring hospitalization before upgrading.
At FU after CRT, NYHA Class decreased to 2.3 ± 0.5; a
≥ 1 NYHA Class improvement was seen in 44/62 patients,
19 with IC and 25 with NIC (p < 0.005). Figure 2.
No myocardial ischemic events from the time of CRT
upgrade to the time of FU was documented in this sub-
set of patients.
In the overall population QRS duration decreased
from 180 ± 20 to 114 ± 11 msec (p < 0.01). No relation
between QRS duration changes, NYHA Class and LVEF
increase could be reported in the studied group.
At FU LVEDD changed from 65.2 ± 7.6 to 63.3 ± 7.9
mm (p < 0.1), LVESD from 55.2 ± 7.9 to 51.2 ± 8.4 mm
(p < 0.001) and LVEF increased from 25.6 ± 6.1 to 31.4
± 9.1% (p < 0.001). However, a >10% decrease in
LVESD, as an index of consistent LV reverse remodeling
after CRT, was observed in 24 patients only.
Figure 1 Left ventricular ejection fraction (LVEF%) changes from pre conventional pacemaker implantation [pre PM] to pre upgrading
[pre CRT] in the studied population.
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with and without reverse remodeling are reported. The
only significant difference between the two groups was
reported for duration of RV pacing (73 vs 37 months in
pts with and without reverse LV remodeling, respec-
tively, p < 0.01).
As far as mitral regurgitation, the scores calculated
before CRT and at follow up changed from 2.3 ± .8 to
2.1 ± .8, NS; however, when groups were divided
according to >10% decrease in LVESD, a significant
reduction could be reported in the group with reverse
remodeling (from 2.2 ± .6 to 1.6 ± .6, p < 0.05) as com-
pared to patients with no significant changes in LVESD
(from 2.4 ± .8 to 2.4 ± .7).
I nt e r m so fe t i o l o g yo fL Vd y s f u n c t i o n ,5 / 3 4p a t i e n t s
with IC showed a >10% decrease in LVESD compared
to 19/28 NIC patients (p < 0.001). Figure 3.
No differences in pre-CRT QRS duration, NYHA Class,
LVEF, LVEDD, LVESD, ongoing treatment, site of LV lead
implant, or duration of RV pacing could be observed
between the 28 NIC patients vs the 34 IC patients (Table
2). Patients with NIC had a slightly, although not
Figure 2 NYHA Class data in the studied patients before RV implantation, before CRT and at FU are reported in the figure.
Table 1 Clinical and echocardiographic characteristics before upgrading of all patients and of those with or without
documented >10% reduction in LVESD after CRT
Total population (n.62) Reverse remodeling (n.24) No reverse remodeling (n.38) p
Age (years) 73 ± 7.8 73.4 ± 8.2 72.6 ± 7.6 NS
NYHA Class 3.2 ± 0.6 3.2 ± 0.4 3.2 ± 0.5 NS
LVEF (%) 25.6 ± 6.1 26.4 ± 6.3 25.2 ± 6.0 NS
LVEDD (mm) 65.2 ± 7.7 65.9 ± 8.1 64.8 ± 7.6 NS
LVESD (mm) 55.2 ± 7.9 56.4 ± 8.4 54.4 ± 7.6 NS
Months of RV pacing 51.2 ± 38.9 73.2 ± 57.4 37.3 ± 38.2 * P < 0.01
ACE-I or ARB (%) 85 84 86
Beta blocker (%) 90 91 89
Diuretics (%) 92 91 93
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to the IC patients (2.15 ± 2.1 vs 2.26 ± 2.3).
I nam u l t i v a r i a t ea n a l y s i sb ym u l t i p l el o g i s t i cr e g r e s -
sion, the association between cause of LV dysfunction
with >10% LVESD decrease remained highly significant
(p < 0.001) also adjusting for pre-CRT QRS duration,
N Y H AC l a s s ,L V E F ,L V E D D ,L V E S D ,o n g o i n gt r e a t -
ment, site of LV lead implant, or duration of RV pacing.
(Table 3).
In the IC group, the 24 patients with documented pre-
vious MI had NYHA Class, LVEF and LVESD, WMSI at
echocardiography, comparable to those obtained in the
10 patients without MI.
Discussion
The results of this study confirm previously published
data that RV apical pacing may lead to overall reduction
in LV global function. Upgrading to CRT improved
NYHA Class in over 70% of patients but a significant
reduction in LVESD at a mean of 1 year FU was
observed in the majority of patients with NIC, while it
was less evident in IC patients.
RV apical pacing is associated with asynchronous elec-
trical activation of the left ventricle which impairs car-
diac systolic and diastolic function and induces regional
perfusion defects even in the absence of coronary artery
disease [22-25].
Upgrading to CRT may determine improvement in
clinical symptoms, LV globalf u n c t i o na n dr e d u c e so r
abolishes dyssynchrony in chronically paced patients
[12,13,16,26,27] leading to left ventricular reverse remo-
deling in a way similar to primary CRT [14,15].
Molhoek et al. demonstrated comparable benefits
from primary CRT in patients with ischemic vs non-
ischemic cardiomyopathy in terms of NYHA Class, qual-
ity of life, and LVEF [28]. However, larger studies have
shown that NIC patients arem o r el i k e l yt oi m p r o v e
clinically and functionally. In the PROSPECT study a
greater decrease in LV end systolic volumes was docu-
mented in patients with non-ischemic HF when com-
pared to those with an ischemic substrate [29].
Accordingly the MIRACLE and CARE-HF studies
showed that reverse LV remodeling occurs to a lesser
degree in patients with ischemic etiology [30,31]. Hyper-
responders, defined as those who show complete func-
tional recovery up to normalization of LV function after
CRT are almost exclusively seen in non-ischemic
Figure 3 Distribution of patients according to etiology of LV dysfunction and changes in end systolic dimensions (ESD) at FU.I C :
ischemic cardiomyopathy; NIC: non ischemic cardiomyopathy.
Table 2 Clinical and echocardiographic characteristics
before upgrading of patients with IC or NIC
IC (n.28) NIC (n.34) p
Age (years) 70.1 ± 8.0 74.5 ± 7.3 NS
NYHA Class 3.3 ± 0.5 3.2 ± 0.4 NS
LVEF (%) 26.0 ± 6.7 25.3 ± 5.7 NS
LVEDD (mm) 66.9 ± 8.0 63.8 ± 7.3 NS
LVESD (mm) 56.7 ± 9.1 54.0 ± 6.7 NS
Months of RV pacing 51.4 ± 42.4 47.5 ± 40.9 NS
LVEF: left ventricular ejection fraction, LVEDD: left ventricular end diastolic
dimensions, LVESD: left ventricular end systolic dimensions. RV: right
ventricular
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point of view, large areas of myocardial scar in ischemic
cardiomyopathy may determine complex patterns of LV
activation that are not amenable of correction with CRT
[34]. In addition, areas of the scar as occurring in post
ischemic LV dysfunction may limit LV reverse remodel-
ing after CRT. Therefore, it is understandable that non-
ischemic HF patients may show LV reverse remodeling
to a larger extent than ischemic patients [35].
In this study clinical improvement was reported in a
high percentage of patients, comparable to previously
published data. Reverse LV remodeling could be found
in only 24 patients; of these, 19 had a non-ischemic
etiology of underlying LV dysfunction.
In heart failure patients, reversal of LV remodeling
after pharmacologic treatment has important prognostic
implications, as previouslyd o c u m e n t e di nt h eS O L V D
study [36]. Prognosis after CRT was shown to be related
to the extent of LV reverse remodeling, more than to
clinical response [33,37,38]). The definition of LV
r e v e r s er e m o d e l i n gi sh i g h l yv a r i a b l ei nl i t e r a t u r ea n d
changes in LV volumes or diameters have been consid-
ered by different AA [29-33]. In line with previously
published papers from our group [39] we defined
reverse remodelling as a >10% reduction in LVESD; low
reproducibility and inaccuracy of the methods com-
monly used for volume calculations by 2D echocardio-
graphy are known, possibly due to the inadvertent use
of foreshortened views of the left ventricle and the reli-
ance on geometric modeling [40]. End systolic diameter
measurement of is then more reliable, in particular in
patients with ischemic dysfunction.
It is important to say that baseline characteristics in
NIC and IC were comparable before CRT, in terms of
treatment, QRS duration, PM implantation duration,
baseline LV function. Interestingly, patients who had
been under RV apical pacing for longer periods were
those who showed the best functional recovery after
upgrading. A possible explanation may be represented
by the chronic detrimental effect on LV function
provided by right ventricular pacing, which can be
reverted by LV resynchronization. Tse et al [9], have
shown that long periods of right ventricular pacing
result in a high incidence of myocardial perfusion
defects. It can be speculated that in these patients
upgrading may abolish or attenuate the perfusion
defects leading to left ventricular contractile improve-
ment and reduction in end systolic dimensions. In
patients in whom upgrading was performed after a short
period of RV apical pacing due to clinical and functional
worsening, the lack of LV reverse remodeling could
have been attributed more to the natural history of the
disease, and the correction of dyssynchrony unable to
counteract the decline in overall LV function. Another
interesting result is represented by the role of LVEDD
and LVESD before implant: while LVEDD is a negative
factor for LV remodeling after CRT, a bigger LVESD
may be a predictor of recovery after upgrading. In a pre-
viously published paper, patients who were super
responders (>30% reduction in end-systolic volume) and
responders after de novo CRT were those showing big-
ger baseline end-systolic volumes, as compared to
patients who functionally worsened at 6 months FU
[33].
In conclusion, upgrading to CRT determines improve-
ment in NYHA class in a good percentage of patients.
Significant LV reverse remodeling is more likely to
occur in patients with non-ischemic cardiomyopathy.
Long FU are needed to identify with proper viability/
contractility studies [41,42] patients who may really ben-
efit from upgrading to CRT.
Limitations
The main limitation of this study is that it is a single-
center and retrospective cohort study. However clinical
data after conventional PM implantation were collected
systematically at each programmed out-patient check-up
and echocardiograms were analyzed by two reviewers
who were blinded to patient name and date of
examination.
Table 3 Predictors of reverse left ventricular remodeling at univariate and multivariate analysis by Cox model
Variables Univariate HR (95% CI) P value Multivariate HR(95% CI) P value
NIC 12.24 (3.55-42.18) <0.001 26.27 (0.37-158) <0.001
QRS duration 1.02 (0.99-1.04) 0.206 1.01 (0.97-1.05) 0.664
NYHA 0.99 (0.31-3.12) 0.985 1.16 (0.20-6.68) 0.867
Site of implant PL 0.69 (0.23-2.06) 0.686 0.48 (0.09-2.71) 0.412
Site of implant A 0.48 (0.08-3.03) 0.435 0.06 (0.004-1.03) 0.053
RV pacing (mo) 1.02 (1.004-1.03) 0.013 1.03 (1.01-1.05) 0.012
LVEF 1.03 (0.95-1.12) 0.438 1.19 (0.97-1.47) 0.101
LVEDD 1.02 (0.95-1.09) 0.589 0.76 (0.59-0.99) 0.044
LVESD 1.04 (0.97-1.11) 0.299 1.35 (1.01-1.82) 0.044
Legend: NIC: non ischemic cardiomyopathy. PL: postero-lateral. A: Anterior. Mo: months HR: hazard Ratio. See text for other abbreviations.
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LV: left ventricle; RV: right ventricle; LVESD: LV end-systolic dimensions;
LVEDD: LV end-diastolic dimensions; NIC: Non-ischemic cardiomyopathy; IC:
Ischemic cardiomyopathy; WMSI wall motion score index; PL: Posterolateral;
A: anterior.
Acknowledgements
The AA wish to thank Ms Alison Frank for her editorial and technical
assistance.
Author details
1CNR Clinical Physiology Institute, via G Moruzzi 1, 56124 Pisa, Italy.
2Fondazione Toscana Gabriele Monasterio, via G Moruzzi 1, 56124 Pisa, Italy.
Authors’ contributions
MAM Concept/design. US Data analysis. GR Statistics. LP Data collection. AR
Data collection. MP Critical revision and approval of the article. All Authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 28 September 2011 Accepted: 16 December 2011
Published: 16 December 2011
References
1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E,
Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ,
Underwood J, Pickering F, Truex C, McAtee P, Messenger J, MIRACLE Study
Group: Multicenter InSync Randomized Clinical Evaluation. Cardiac
resynchronization in chronic heart failure. N Engl J Med 2002,
346:1845-1853.
2. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S,
Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC, Multisite
Stimulation in Cardiomyopathies (MUSTIC) Study Investigators: Effects of
multisite biventricular pacing in patients with heart failure and
intraventricular conduction delay. N Engl J Med 2001, 344:873-880.
3. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L,
Tavazzi L, Cardiac Resynchronization-Heart Failure [CARE-HF] Study
Investigators: The effect of cardiac resynchronization on morbidity and
mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
4. Rossi A, Rossi G, Startari U, Panchetti L, Piacenti M, Morales MA: The current
role of cardiac resynchronization therapy in reducing mortality and
hospitalization in heart failure patients. A meta-analysis from clinical trials.
Heart Vessels 2008, 4:217-223.
5. Nahlawi M, Waligora M, Spies SM, Bonow RO, Kadish AH, Goldberger JJ:
Left ventricular function during and after right ventricular pacing. JA m
Coll Cardiol 2004, 44:1883-1888.
6. Sweeney MO, Helkamp AS, Ellenbogen KA, Greenspon AJ, Freedman FA,
Lee KL, Lamas GA, for the Mode Selection Trial (MOST) Investigators:
Adverse of effects of ventricular pacing on heart failure and atrial
fibrillation among patients with normal baseline QRS duration in a
clinical trial of pacemaker therapy for sinus node dysfunction. Circulation
2003, 107:2932-2937.
7. Rosenqvist M, Isaaz K, Botvinick EH, Dae MW, Cockrell J, Abbott JA,
Schiller NB, Griffin JC: Relative importance of activation sequence
compared to atrioventricular synchrony in left ventricular function. Am J
Cardiol 1991, 67:148-156.
8. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER: Mapping of regional
myocardial strain and work during ventricular pacing: Experimental
study using magnetic resonance imaging tagging. J Am Coll Cardiol 1999,
133:1735-1742.
9. Sato-Iino T, Watanabe H, Koyama T, Iino K, Kosaka T, Ito H: The prevalence
of apical wall motion abnormalities in patients with long-term right
ventricular apical pacing. J Am Soc Echocardiogr 2011, 24:556-564.
10. Thackray SD, Witte KK, Nikitin NP, Clark AL, Kaye GC, Cleland JG: The
prevalence of heart failure and asymptomatic left ventricular systolic
dysfunction in a typical regional pacemaker population. Eur Heart J 2003,
24:1143-1152.
11. Tantengco MV, Thomas RL, Karpawich PP: Left ventricular dysfunction
after long-term right ventricular apical pacing in the young. JACC 2001,
37:2093-2100.
12. Witte KK, Pipes RR, Nanthakumar K, Parker JD: Biventricular pacemaker
upgrade in previously paced heart failure patients–improvements in
ventricular dyssynchrony. J Card Fail 2006, 2:199-204.
13. Horwich T, Foster E, De Marco T, Tseng Z, Saxon L: Effects of
resynchronization therapy on cardiac function in pacemaker patients
“upgraded” to biventricular devices. J Cardiovasc Electrophysiol 2004,
5:1284-1289.
14. Fröhlich G, Steffel J, Hürlimann D, Enseleit F, Lüscher TF, Ruschitzka F,
Abraham WT, Holzmeister J: Upgrading to resynchronization therapy after
chronic right ventricular pacing improves left ventricular remodeling. Eur
Heart J 2010, 31:1477-1485.
15. Vatankulu MA, Goktekin O, Gurkan Kaya M, Ayhan S, Kucukdurmaz Z,
Sutton R, Henein M: Effect of Long-Term Resynchronization Therapy on
left Ventricular Remodeling in Pacemaker Patients Upgraded to
Biventricular Devices. Am J Cardiol 2009, 103:1280-1284.
16. Dilaveris P, Pantazis A, Giannopoulos G, Synetos A, Gialafos J, Stefanadis C:
Upgrade to biventricular pacing in patients with pacing-induced heart
failure: can resynchronization do the trick? Europace 2006, 8:352-357.
17. Marsan NA, Bleeker GB, van Bommel RJ, Ypenburg C, Delgado V, Borleffs CJ,
Holman ER: Comparison of time course of response to cardiac
resynchronization therapy in patients with ischemic versus nonischemic
cardiomyopathy. Am J Cardiol 2009, 103:690-694.
18. Wikstrom G, Blomström-Lundqvist C, Andren B, Lönnerholm S,
Blomström P, Freemantle N, Remp T, Cleland JG, CARE-HF study
investigators: on behalf of the CARE-HF study investigators The effects of
etiology on outcome in patients treated with cardiac resynchronization
therapy in the CARE-HF trial. Eur Heart J 2009, 30:782-788.
19. Morales MA, Startari U, Panchetti L, Rossi A, Piacenti M: Atrioventricular
delay optimization by Doppler-derived left ventricular dP/dt improves 6-
month outcome of resynchronized patients. Pacing Clin Electrophysiol
2006, 29:564-568.
20. Schiller NB, Acquatella H, Ports TA, Drew D, Goerke J, Ringertz H,
Silverman NH, Brundage B, Botvinick EH, Boswell R, Carlsson E, Parmley WW:
Left ventricular volume from paired biplane two-dimensional
echocardiography. Circulation 1979, 60:547-555.
21. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA,
Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ,
Waggoner A, Weissman NJ, American Society of Echocardiography:
Recommendations for evaluation of the severity of native valvular
regurgitation with two-dimensional and Doppler echocardiography. J
Am Soc Echocardiogr 2003, 16(7):777-802.
22. Kachboura S, Ben Halima A, Fersi I, Marrakchi S, Zouaoui W, Kammoun I:
Assessment of heart failure and left ventricular systolic dysfunction after
cardiac pacing in patients with preserved left ventricular systolic
function. Ann Cardiol Angeiol 2008, 57:29-36.
23. Tse HF, Yu C, Wong KK, Tsang V, Leung YL, Ho WY, Lau CP: Functional
abnormalities in patients with permanent right ventricular pacing. The
effect of sites of electrical stimulation. J Am Coll Cardiol 2002,
40:1451-1458.
24. Tse HF, Lau CP: Long-term effect of right ventricular pacing on
myocardial perfusion and function. J Am Coll Cardiol 1997, 29:744-749.
25. Skalidis EI, Kochiadakis GE, Koukouraki SI, Chrysostomakis SI,
Igoumenidis NE, Karkavitsas NS, Vardas PE: Myocardial perfusion in
patients with permanent ventricular pacing and normal coronary
arteries. J Am Coll Cardiol 2001, 37:124-129.
26. Rosen BD, Berger RD: Resynchronization therapy upgrades: turning coach
into first class. J Cardiovasc Electrophysiol 2004, 15:1290-1292.
27. Baker CM, Christopher TJ, Smith PF, Langberg JJ, Delurgio DB, Leon AR:
Addition of a left ventricular lead to conventional pacing systems in
patients with congestive heart failure: feasibility, safety, and early results
in 60 consecutive patients. Pacing Clin Electrophysiol 2002, 25:1166-1171.
28. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P:
Comparison of benefits from cardiac resynchronization therapy in
patients with ischemic cardiomyopathy versus idiopathic dilated
cardiomyopathy. Am J Cardiol 2004, 93:860-863.
29. van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, Tavazzi L,
Zimetbaum PJ, Gerritse B, Kristiansen N, Ghio S: Characteristic of heart
Morales et al. Cardiovascular Ultrasound 2011, 9:41
http://www.cardiovascularultrasound.com/content/9/1/41
Page 7 of 8failure patients associated with good and poor response to CRT: a
PROSPECT sub analysis. Eur Heart J 2009, 30:2470-2477.
30. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E:
Sustained reverse left ventricular structural remodeling with cardiac
resynchronization at one year is a function of etiology: quantitative
Doppler echocardiographic evidence from the Multicenter InSync
Randomized Clinical Evaluation (MIRACLE). Circulation 2006, 113:266-72.
31. Ghio S, Freemantle N, Scelsi L, Serio A, Magrini G, Pasotti M, Shankar A,
Cleland JG, Tavazzi L: Long term ventricular reverse remodelling with
cardiac resynchronization therapy: results from the CARE-HF trial. Eur J
Heart Fail 2009, 1:480-488.
32. Castellant P, Fatemi M, Bertault-Valls V, Etienne Y, Blanc JJ: Cardiac
resynchronization therapy: “nonresponders” and “hyperresponders”.
Heart Rhythm 2008, 5:193-197.
33. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ,
Bax JJ: Long-Term prognosis after cardiac resynchronization therapy is
related to the extent of left ventricular reverse remodeling at midterm
follow-Up. J Am Coll Cardiol 2009, 53:483-490.
34. Sweeney MO, Prinzen FW: Ventricular pump function and pacing:
physiological and clinical integration. Circ Arrhythm Electrophysiol 2008,
1:127-39.
35. Ypenburg C, Roes SD, Bleeker GB, et al: Effect of total scar burden
oncontrast-enhanced magnetic resonance imaging on response to
cardiac resynchronization therapy. Am J Cardiol 2007, 99:657-60.
36. Konstam MA, Kronenberg MW, Rousseau MF, Udelson JE, Melin J,
Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, Howe DM, Kilcoyne L,
Metherall J, Benedict C, Yusuf S, Pouleur H, for the SOLVD investigators:
Effects of angiotensin converting enzyme inhibitor ebalapril on the
long-term progression of left ventricular dysfunction in patients with
heart failure. Circulation 1992, 86:431-438.
37. Woo GW, Petersen-Stejskal S, Johnson JW, Conti JB, Aranda JA Jr, Curtis AB:
Ventricular reverse remodeling and 6-month oucomes in patient
receiving cardiac resynchronization therapy: analysis of the MIRACLE
study. J Interv Card Electrophysiology 2005, 12:107-113.
38. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, van der Wall EE, Chan YS,
Kong SL, Bax JJ: Left ventricular reverse remodeling but not clinical
improvement predictslong-term survival after cardiac resynchronization
therapy. Circulation 2005, 112:1580-1586.
39. Morales MA, Maltinti M, Piacenti M, Turchi S, Giannessi D, Del Ry S:
Adrenomedullin plasma levels predict left ventricular reverse
remodeling after cardiac resynchronization therapy. Pacing Clin
Electrophysiol 2010, 33:865-72.
40. Caiani EG, Corsi C, Zamorano J, Sugeng L, MacEneaney P, Weinert L,
Battani R, Gutierrez JL, Koch R, Perez de Isla L, Mor-Avi V, Lang RM:
Improved semi-automated quantification of left ventricular volumes and
ejection fraction using high-resolution real-time three-dimensional
echocardiography: comparison with MRI. J Am Soc Echocardiogr 2005,
18:779-788.
41. Ciampi Q, Pratali L, Citro R, Villari B, Picano E, Sicari R: Clinical and
prognostic role of pressure-volume relationship in the identification of
responders to cardiac resynchronization therapy. Am Heart J 2010,
160(5):906-14.
42. Moonen M, Senechal M, Cosyns B, Melon P, Nellessen E, Pierard L,
Lancellotti P: Impact of contractile reserve on acute response to cardiac
resynchronization therapy. Cardiovasc Ultrasound 2008, 6:65.
doi:10.1186/1476-7120-9-41
Cite this article as: Morales et al.: Reverse left ventricular remodeling is
more likely in non ischemic cardiomyopathy patients upgraded to
biventricular stimulation after chronic right ventricular pacing.
Cardiovascular Ultrasound 2011 9:41.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Morales et al. Cardiovascular Ultrasound 2011, 9:41
http://www.cardiovascularultrasound.com/content/9/1/41
Page 8 of 8